Chesapeake Research Group, LLC is a clinical study investigative site dedicated to supporting our clients in the development of products by conducting rigorous and efficient clinical drug/device trials.
Our staff is committed to producing and submitting clean and precise data in a timely fashion. We are a multi-specialty site that has established affiliations with primary care and other specialty groups.
Dr. Gottlieb was a researcher/investigator working as a consultant for a research group. At the same time, Deborah Tunick worked as a nurse at the same site. When the site closed its doors, Dr. Gottlieb and Deborah joined together and opened Chesapeake Research Group.
“The Chesapeake Research Group, headed by Dr. Ira Gottlieb, is a highly experienced facility for clinical trial research. We have worked with Dr. Gottlieb and his team on multiple trials and in multiple phases of development. They specialize in research related to the treatment of acute pain, especially postoperative pain using surgical models. Refreshingly, they do what they say they can do and deliver clean data in a timely fashion. They have a deep understanding of what it takes to comply with all of the regulatory requirements. Their commitment is also reflected in the excellent care of the patients.”
–James Campbell, M.D., President and Chief Scientific Officer of Centrexion Therapeutics and Professor Emeritus of neurosurgery at Johns Hopkins University School of Medicine
“We have always found Chesapeake Research Group to be an extremely professional and thorough clinical research site that delivers accurate and timely information. They have played an important role in our studies and remain at the top of our list for Baltimore – Washington, D.C. area sites.”
-Gabrielle Poirier, Clinical Project Manager
“It was a privilege to work with Chesapeake Research Group. The site enrolled quickly, the protocol was followed without deviations, data was high quality, and the site promptly responded to any sponsor request. Site staff was experienced in clinical research, provided optimal care of study patients, and adhered to all regulations while always being pleasant.”
-Rosemary Keller PhD CRNP, Senior Clinical Scientist, Recro Pharma